Abiopharma

🔍 Salem Enrique T (Executive)

Company: DOCUSIGN, INC. (DOCU)

Report Date: 2026-05-29

Detailed Transactions and Holdings:

• Acquired 729 shares of Common Stock (Direct)
  Date: 2026-05-29 | Code: M | equity_swap_involved: false | shares_owned_after: 167,318.00 | transaction_form_type: 4
• Sold 729 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-29 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 4,384 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-01 | Code: A | equity_swap_involved: false | shares_owned_after: 4,384.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
• F2: The RSUs have a vest commencement date of May 29, 2025 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date. The RSUs do not expire.
• F3: The RSUs have a vesting commencement date of June 1, 2026 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date. The RSUs do not expire.